Notes on FK 506.
作者信息
Starzl T E, Fung J, Todo S, Tzakis A
机构信息
Department of Surgery University Health Center of Pittsburgh, University of Pittsburgh, Pennsylvania.
出版信息
Transplant Proc. 1991 Aug;23(4):2178-9.
Abstract
摘要
相似文献
1
Notes on FK 506.关于FK 506的笔记。
Transplant Proc. 1991 Aug;23(4):2178-9.
2
Small bowel transplantation in sensitized recipients: comparison with heart, kidney, and liver grafts.致敏受者的小肠移植：与心脏、肾脏和肝脏移植的比较。
Transplant Proc. 1994 Jun;26(3):1517-8.
3
Overview of FK506 in transplantation.FK506在移植中的概述。
Clin Transpl. 1990:115-21.
4
Prevention of sensitization and hyperacute rejection in liver and heart xenografts by FK 506 plus donor antigens.FK506联合供体抗原预防肝和心脏异种移植中的致敏和超急性排斥反应。
Transplant Proc. 1995 Feb;27(1):277.
5
FK 506 dose in transplantation: from theory to practice.移植中FK 506的剂量：从理论到实践
Transplant Proc. 2001 Jun;33(4):2594-7. doi: 10.1016/s0041-1345(01)02107-8.
6
Treatment of transplant rejection in the presence of cytomegalovirus viremia.
Transplant Proc. 1990 Aug;22(4):1815-7.
7
FK 506 for liver, kidney, and pancreas transplantation.用于肝脏、肾脏和胰腺移植的FK 506。
Lancet. 1989 Oct 28;2(8670):1000-4. doi: 10.1016/s0140-6736(89)91014-3.
8
Induction of liver, heart, and multivisceral graft acceptance with a short course of FK 506.采用短期FK 506诱导肝脏、心脏和多脏器移植受者的移植物耐受。
Transplant Proc. 1990 Feb;22(1):74-5.
9
Use of FK 506 in pediatric patients.FK506在儿科患者中的应用。
Transplant Proc. 1991 Feb;23(1 Pt 2):924-7.
10
Tacrolimus in solid organ transplantation: an update.实体器官移植中的他克莫司：最新进展
Transplant Proc. 1999 Sep;31(6):2203-5. doi: 10.1016/s0041-1345(99)00306-1.
引用本文的文献
1
Long-term insulin requirement after liver transplantation with FK 506 in American veterans.美国退伍军人肝移植后使用FK 506的长期胰岛素需求情况。
Transplant Proc. 1993 Feb;25(1 Pt 1):677-8.
2
FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation.骨髓移植后慢性移植物抗宿主病中FK 506的挽救治疗
Transplant Proc. 1991 Dec;23(6):3225-7.
3
Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients.FK 506在小肠移植患者中的静脉给药、口服药代动力学及口服给药
Transplant Proc. 1992 Jun;24(3):1181-2.
本文引用的文献
1
Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat.新型免疫抑制剂FK 506对大鼠异位心脏同种异体移植的影响。
Transplant Proc. 1987 Feb;19(1 Pt 2):1284-6.
2
FK 506 for liver, kidney, and pancreas transplantation.用于肝脏、肾脏和胰腺移植的FK 506。
Lancet. 1989 Oct 28;2(8670):1000-4. doi: 10.1016/s0140-6736(89)91014-3.
3
4
FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.FK-506，一种从链霉菌中分离出的新型免疫抑制剂。II. FK-506的体外免疫抑制作用。
J Antibiot (Tokyo). 1987 Sep;40(9):1256-65. doi: 10.7164/antibiotics.40.1256.
5
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine.单独接受FK-506或与环孢素联合使用时大鼠的异位心脏移植
Transplant Proc. 1987 Oct;19(5 Suppl 6):71-5.
6
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.肝移植受者从环孢素转换为基于FK 506的免疫抑制：益处与风险。
Transplant Proc. 1991 Feb;23(1 Pt 1):14-21.
7
8
A clinical trial of FK 506 as primary and rescue immunosuppression in cardiac transplantation.一项关于FK 506作为心脏移植主要及挽救性免疫抑制药物的临床试验。
Transplant Proc. 1991 Feb;23(1 Pt 2):1149-52.
9
Liver, kidney, and thoracic organ transplantation under FK 506.在使用FK506情况下的肝脏、肾脏及胸部器官移植。
Ann Surg. 1990 Sep;212(3):295-305; discussion 306-7. doi: 10.1097/00000658-199009000-00008.
10
Kidney transplantation under FK 506.在使用FK506的情况下进行肾脏移植。
JAMA. 1990 Jul 4;264(1):63-7.
Zotero 插件